Bausch Health Companies Inc
TSX:BHC

Watchlist Manager
Bausch Health Companies Inc Logo
Bausch Health Companies Inc
TSX:BHC
Watchlist
Price: 11.17 CAD -2.45% Market Closed
Market Cap: 4.1B CAD
Have any thoughts about
Bausch Health Companies Inc?
Write Note

Bausch Health Companies Inc
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bausch Health Companies Inc
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Bausch Health Companies Inc
TSX:BHC
EPS (Diluted)
$0
CAGR 3-Years
47%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Sundial Growers Inc
NASDAQ:SNDL
EPS (Diluted)
CA$0
CAGR 3-Years
36%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
EPS (Diluted)
$0
CAGR 3-Years
48%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
EPS (Diluted)
-$1
CAGR 3-Years
27%
CAGR 5-Years
16%
CAGR 10-Years
0%
K
Knight Therapeutics Inc
TSX:GUD
EPS (Diluted)
CA$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
EPS (Diluted)
$0
CAGR 3-Years
-101%
CAGR 5-Years
-59%
CAGR 10-Years
N/A
No Stocks Found

Bausch Health Companies Inc
Glance View

Market Cap
4.1B CAD
Industry
Pharmaceuticals

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. The company is headquartered in Laval, Quebec and currently employs 19,600 full-time employees. The firm is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices), which are marketed directly or indirectly in over 100 countries. Its segments include Bausch + Lomb, Salix, Ortho Dermatologics, International Rx and Diversified Products. The Bausch + Lomb segment consists of sales in the United States of Bausch + Lomb Vision Care, Consumer, Surgical and Ophthalmology Rx products. The Salix segment consists of sales in the United States of gastroenterology (GI) products. The Ortho Dermatologics segment consists of sales in the United States of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices.

BHC Intrinsic Value
111.27 CAD
Undervaluation 90%
Intrinsic Value
Price

See Also

What is Bausch Health Companies Inc's EPS (Diluted)?
EPS (Diluted)
-0.5 USD

Based on the financial report for Sep 30, 2024, Bausch Health Companies Inc's EPS (Diluted) amounts to -0.5 USD.

What is Bausch Health Companies Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
23%

Over the last year, the EPS (Diluted) growth was 82%. The average annual EPS (Diluted) growth rates for Bausch Health Companies Inc have been 47% over the past three years , 23% over the past five years .

Back to Top